RVL Pharmaceuticals plc (RVLP) has 9 open-market insider trades by 7 insiders since 2022. The most active filer is Harsaul Foundation, 10% Owner.
| Name | Title | Tier | Trades | Value | Last Trade |
|---|---|---|---|---|---|
| David F. Burgstahler | Dir10% | — | 1 | $12.4M | 2023-01-27 |
| Sriram Venkataraman | Dir10% | — | 1 | $12.4M | 2023-01-27 |
| Orbit Co-Invest III LLC | 10% | — | 1 | $12.4M | 2023-01-27 |
| Brian A. Markison | CEO | — | 1 | $1.3M | 2022-08-08 |
| Harsaul Foundation | 10% Owner | — | 2 | $1.2M | 2023-10-20 |
| Altchem Ltd | 10% Owner | — | 2 | $348K | 2023-10-20 |
| James Schaub | EVP and COO | — | 1 | $233K | 2023-05-18 |
| Insider | Title | Type | Value | Date |
|---|---|---|---|---|
| Altchem Ltd | 10% | Sell | $143K | 2023-10-20 |
| Harsaul Foundation | 10% Owner | Sell | $754K | 2023-10-19 |
| Altchem Ltd | 10% | Sell | $205K | 2023-10-18 |
| Harsaul Foundation | 10% Owner | Sell | $411K | 2023-10-18 |
| James Schaub | EVP and COO | Buy | $233K | 2022-08-08 |
| Brian A. Markison | CEO | Buy | $1.3M | 2022-08-08 |
Companies that share insiders with RVLP, and sector peers with recent insider buying. Related by who files, not by how the stocks move.
| Sriram Venkataraman | Director & 10% | Buy | $12.4M | 2022-08-08 |